B-cell therapy for MS may impact COVID-19 vaccinationMarch 3, 2022Multiple SclerosisMultiple Sclerosis
Clinical Edge Journal Scan Commentary: Multiple Sclerosis March 2022February 23, 2022Multiple Sclerosis
Early decline in lymphocyte count best predicts DMF-associated lymphopenia in relapsing MSFebruary 22, 2022Multiple Sclerosis
Primary progressive MS: No difference in efficacy between rituximab and ocrelizumab in real worldFebruary 22, 2022Multiple Sclerosis
sNfL and disease course in progressive MS without acute inflammation: Is there a link?February 22, 2022Multiple Sclerosis
High or increasing sNfl level predictive of impending relapses in active multiple sclerosisFebruary 22, 2022Multiple Sclerosis
Multiple sclerosis: Excellent response to SARS-CoV-2 vaccine in patients with MSFebruary 22, 2022Multiple Sclerosis
Differential impact of multiple sclerosis therapies on SARS-CoV-2 vaccine-induced immune responseFebruary 22, 2022Multiple Sclerosis
Multiple sclerosis: Evidence spanning 3 decades finds no influence of DMTs on neoplasm incidenceFebruary 22, 2022Multiple Sclerosis
Multiple sclerosis relapses are prevalent after natalizumab cessation during pregnancyFebruary 22, 2022Multiple Sclerosis
Third COVID-19 vaccine dose shows benefit in MS patients with a weak response after 2 dosesFebruary 22, 2022Multiple Sclerosis
Clinical Edge Journal Scan Commentary: Multiple Sclerosis February 2022February 1, 2022Multiple Sclerosis
